Skip to content

No CD4 plateau found after 4 years on HAART in those with prior severe immune suppression

Two rare cases of family HIV transmission between adults reported

Treatment response at six months best guide to long-term prognosis

Treatment interruption shows no benefit in HIV patients with drug resistance

New US HIV lipid guidelines favour lifestyle changes over drug therapy as first line

HAART optimism means HIV-positive IV drug users more likely to have unsafe sex and share needles

Nevirapine for PEP: should use be restricted due to liver toxicity risk?

Computer model says vaccines and treatment both needed to turn tide of HIV

Success and failure in HIV treatment: contrasting lessons from South Africa